Literature DB >> 12960347

Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor.

Jeannie M Gripentrog1, Katrin P Kantele, Algirdas J Jesaitis, Heini M Miettinen.   

Abstract

A large number of G protein-coupled receptors have been shown to form homodimers based on a number of different techniques such as receptor coimmunoprecipitation, cross-linking, and fluorescence resonance energy transfer. In addition, functional assays of cells coexpressing a mutant receptor with a wild-type receptor have shown receptor phenotypes that can best be explained through dimerization. We asked whether the human neutrophil N-formyl peptide receptor (FPR) forms dimers in Chinese hamster ovary cells by coexpressing wild-type FPR with one of two mutants: D71A, which is uncoupled from G protein, and N297A, which has a defect in receptor phosphorylation and endocytosis. Experiments measuring chemotaxis, ligand-induced release of intracellular calcium, and p42/44 mitogen-activated protein kinase activation did not show an inhibitory effect of the coexpressed FPR D71A mutant. Coexpressed wild-type receptor was efficiently internalized, but failed to correct the endocytosis defects of the D71A and the N297A mutants. To explore the possibility that the mutations themselves prevented dimerization, we examined the coimmunoprecipitation of differentially epitope-tagged FPR. Immunoprecipitation of hemagglutinin-tagged FPR failed to coimmunoprecipitate coexpressed c-myc-tagged FPR and vice versa. Together, these data suggest that, unlike many other G protein-coupled receptors, FPR does not form homodimers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960347     DOI: 10.4049/jimmunol.171.6.3187

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.

Authors:  Jeannie M Gripentrog; Heini M Miettinen
Journal:  Cell Signal       Date:  2007-11-09       Impact factor: 4.315

Review 2.  Cross-talk and modulation of signaling between somatostatin and growth factor receptors.

Authors:  Ujendra Kumar
Journal:  Endocrine       Date:  2011-08-26       Impact factor: 3.633

3.  Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging.

Authors:  Rinshi S Kasai; Kenichi G N Suzuki; Eric R Prossnitz; Ikuko Koyama-Honda; Chieko Nakada; Takahiro K Fujiwara; Akihiro Kusumi
Journal:  J Cell Biol       Date:  2011-02-07       Impact factor: 10.539

Review 4.  The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer.

Authors:  Weiwei Liang; Keqiang Chen; Wanghua Gong; Teizo Yoshimura; Yingying Le; Ying Wang; Ji Ming Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-24       Impact factor: 5.555

5.  Pro-Resolving FPR2 Agonists Regulate NADPH Oxidase-Dependent Phosphorylation of HSP27, OSR1, and MARCKS and Activation of the Respective Upstream Kinases.

Authors:  Rosario Ammendola; Melania Parisi; Gabriella Esposito; Fabio Cattaneo
Journal:  Antioxidants (Basel)       Date:  2021-01-19

6.  Variable responses of formyl peptide receptor haplotypes toward bacterial peptides.

Authors:  Jeannie M Gripentrog; John S Mills; George J Saari; Heini M Miettinen
Journal:  Immunogenetics       Date:  2008-02-06       Impact factor: 2.846

7.  CD177-mediated nanoparticle targeting of human and mouse neutrophils.

Authors:  Heini M Miettinen; Jeannie M Gripentrog; Connie I Lord; Jon O Nagy
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

Review 8.  The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview.

Authors:  Marie-Josèphe Rabiet; Emilie Huet; François Boulay
Journal:  Biochimie       Date:  2007-03-03       Impact factor: 4.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.